Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2000
03/07/2000US6034212 SH3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof
03/07/2000US6034211 Diarylheterocycle amino acid, n-methylated residues
03/07/2000US6034175 Biopolymer insert
03/07/2000US6034135 Delivering anionic macromolecule to cell
03/07/2000US6034104 Anticoagulant agents
03/07/2000US6034097 Isoquinolines useful as analgesics
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6034072 Genetic engineering; anticancer, antitumor agent
03/07/2000US6034067 Serine protease inhibitors
03/07/2000US6034066 Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases
03/07/2000US6034065 Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10
03/07/2000US6034064 Polypeptide
03/07/2000US6034063 Human phosphatidylinositol transfer protein gamma
03/07/2000US6034062 Bone morphogenetic protein (BMP)-9 compositions and their uses
03/07/2000US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein
03/07/2000US6034060 Peptide having an ability to promote the activation of protein C by thrombin
03/07/2000US6034059 Treatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrients
03/07/2000US6034058 Administering polypeptide
03/07/2000US6034057 Cyclic octapeptide; antiarthritic agent
03/07/2000US6034056 Cyclic peptides; antiarthritic agents
03/07/2000US6034055 Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars
03/07/2000US6034054 Solution containing tris buffer, arginine, zinc and preservative
03/07/2000US6034053 Vascular disorders
03/07/2000US6033915 Materials and method for the detection and treatment of Wegener's granulomatosis
03/07/2000US6033894 Kaposi's Syndrome Herpesvirus protease and assembly protein compositions and methods
03/07/2000US6033893 Use of these sequences in the diagnosis, prevention, and treatment of disorders associated with cell proliferation.
03/07/2000US6033889 The protein is used as a necessary medicament in treatment of inflammation, disease of autoimmunization,or chromosome lesion.
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033876 The antibodies may be used for diagnosis, or conjugated to a toxin to produce an immunotoxin.
03/07/2000US6033873 Cytokine suppressive anti-inflammatory drug (csaid) binding proteins csbp.beta.
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033871 Screening methods for identifying drugs that interact with the imidazoline receptor are described.
03/07/2000US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation.
03/07/2000US6033865 Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same and uses therefor
03/07/2000US6033864 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
03/07/2000US6033708 Blood substitutes, more specifically, a method for producing an oxygen-carrying encapsulated hemoglobin material that is sterile filterable.
03/07/2000US6033688 Cystic fibrosis therapy
03/07/2000US6033670 Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus
03/07/2000US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby
03/07/2000US6033664 Use of a preparation comprising a plasminogen activator to improve wound healing
03/07/2000US6033662 Oxygen activatable formulations for disinfection or sterilization
03/07/2000US6033661 Composition and method for allogenetic mononuclear cell immunotherapy
03/07/2000US6033654 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
03/07/2000CA2175892C Kinase receptor activation assay
03/02/2000WO2000011478A1 Assays, methods and means for modulating nuclear localisation
03/02/2000WO2000011217A1 Compounds and methods for enhancing delivery of free polynucleotide
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011204A2 Homer interacting proteins
03/02/2000WO2000011202A1 Cationic complexes of polymer-modified adenovirus
03/02/2000WO2000011201A1 Targeted alphavirus and alphaviral vectors
03/02/2000WO2000011195A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011184A1 Staphylococcus aureus polypeptides
03/02/2000WO2000011174A1 Human il-1 epsilon dna and polypeptides
03/02/2000WO2000011173A1 Leptin-related peptides
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011168A2 Genes that regulate hematopoietic blood forming stem cells and uses thereof
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000WO2000011166A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000WO2000011165A1 ROLE OF HUMAN KIS (hKIS) AS AN INHIBITORY KINASE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27. COMPOSITIONS, METHODS AND USES THEREOF TO CONTROL CELL PROLIFERATION
03/02/2000WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000WO2000011162A1 Modulation of apoptosis with bid
03/02/2000WO2000011161A1 Novel collectin
03/02/2000WO2000011160A1 Grip, human adapter protein related to the grb2 family member
03/02/2000WO2000011159A1 Pharmaceutical composition for treating or preventing diabetes or cancer, or the waardenburg syndrome
03/02/2000WO2000011157A1 Dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy
03/02/2000WO2000011152A1 Streptavidin mutants having secondary functional domains
03/02/2000WO2000011151A2 Direct oviduct transgenesis
03/02/2000WO2000011150A1 Cell surface immunomodulators
03/02/2000WO2000011146A1 Artiodactyl epimorphine
03/02/2000WO2000011141A2 tRNA BINDING DOMAIN
03/02/2000WO2000011036A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120
03/02/2000WO2000011035A1 Hiv suppressor factor derived from scrub typhus
03/02/2000WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins
03/02/2000WO2000011030A2 Method for chromatographically purifying insulins
03/02/2000WO2000011029A2 Novel anti-diabetic peptides
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000011027A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
03/02/2000WO2000011023A2 Ring modified cyclic peptide analogs
03/02/2000WO2000011022A1 Anti-cancer compounds and methods related thereto
03/02/2000WO2000011021A1 5-membered ring compounds
03/02/2000WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent
03/02/2000WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
03/02/2000WO2000011016A1 Dysferlin mutations
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000011014A1 49 human secreted proteins
03/02/2000WO2000011013A1 Modified nucleomonomers and methods of use thereof
03/02/2000WO2000010613A2 Inhibition of smooth muscle cell migration by heme oxygenase 1
03/02/2000WO2000010612A1 Methods to enhance and confine expression of genes
03/02/2000WO2000010609A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000WO2000010604A1 Gene therapy for regulating smooth muscle cell tone
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010602A1 Lats knock-out animal models and their uses
03/02/2000WO2000010600A2 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
03/02/2000WO2000010599A2 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
03/02/2000WO2000010598A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion
03/02/2000WO2000010597A1 Vaccine comprising cytokine-induced heat shock proteins (hsp)
1 ... 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 ... 3163